Palisade Liabilities And Stockholders Equity from 2010 to 2024

PALI Stock  USD 6.36  0.10  1.55%   
Palisade Bio's Liabilities And Stockholders Equity is increasing with very volatile movements from year to year. Liabilities And Stockholders Equity is predicted to flatten to about 12.3 M. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Palisade Bio's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2006-06-30
Previous Quarter
14.1 M
Current Value
12.7 M
Quarterly Volatility
7.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Palisade Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Palisade main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 K, Interest Expense of 14.2 K or Selling General Administrative of 6.6 M, as well as many exotic indicators such as Price To Sales Ratio of 17.64, Dividend Yield of 0.0 or PTB Ratio of 0.34. Palisade financial statements analysis is a perfect complement when working with Palisade Bio Valuation or Volatility modules.
  
This module can also supplement various Palisade Bio Technical models . Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

Latest Palisade Bio's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Palisade Bio over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Palisade Bio's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Palisade Bio's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Very volatile
   Liabilities And Stockholders Equity   
       Timeline  

Palisade Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean12,501,779
Geometric Mean9,992,226
Coefficient Of Variation61.10
Mean Deviation5,747,657
Median12,512,000
Standard Deviation7,638,266
Sample Variance58.3T
Range27.9M
R-Value0.06
Mean Square Error62.6T
R-Squared0
Significance0.84
Slope99,439
Total Sum of Squares816.8T

Palisade Liabilities And Stockholders Equity History

202412.3 M
202314.1 M
202215.8 M
202112.5 M
2020M
20196.6 M
20187.7 M

About Palisade Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Palisade Bio income statement, its balance sheet, and the statement of cash flows. Palisade Bio investors use historical funamental indicators, such as Palisade Bio's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Palisade Bio investors may use each financial statement separately, they are all related. The changes in Palisade Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Palisade Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Palisade Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Palisade Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity14.1 M12.3 M

Currently Active Assets on Macroaxis

When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:
Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Palisade Stock analysis

When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Palisade Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(27.00)
Revenue Per Share
0.548
Return On Assets
(0.54)
Return On Equity
(1.03)
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.